← All US exec pay

Regeneron Pharmaceuticals, Inc. (REGN)

CEO compensation · Health Care · Biotechnology · FY2025
CEO total comp
$8.78M
Sector percentile
59.5th
Sector median
$7.11M
CEO pay ratio
41:1

Versus Health Care peers

Daniel P. Van Plew's FY2025 total of $8.78M ranks at the 59.5th percentile among 174 sector CEOs · sector median $7.11M · p75 $15.12M.

CEO pay mix

CEO total comp over time

Named Executive Officers — FY2025

ExecutiveTitleSalaryBonusStockOptionIncentiveOtherTotalSource
Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply $0.98M—$2.70M $4.05M$0.97M$0.08M $8.78M SEC ↗
Andrew J. Murphy, Ph.D Executive Vice President, Co-Chief Scientific Officer $0.82M—$2.70M $4.05M$0.82M$0.09M $8.48M SEC ↗
Joseph J. LaRosa Executive Vice President, General Counsel and Secretary $0.92M$1.00M$1.80M $2.70M$0.91M$0.13M $7.46M SEC ↗
Leonard S. Schleifer, M.D., Ph.D Board co-Chair, President and Chief Executive Officer $1.98M—$3.68M $1.62M—$0.00M $7.28M SEC ↗
Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer $0.72M—$2.20M $3.30M$0.72M$0.04M $6.99M SEC ↗
George D. Yancopoulos, M.D., Ph.D Board co-Chair, President and Chief Scientific Officer $1.98M—$3.68M $1.29M—$0.00M $6.95M SEC ↗

Every figure links to its source SEC proxy (DEF 14A). Extraction: edgar-html+claude-haiku.